Dysfunctional regulation of GAK in those PD patients who carry the 4p16.3 GWAS risk variant appears to be related to gene transcription related to synaptic and mitochondrial biology, which would drastically affect the neuron’s ability to function properly, especially while under the burden of the aggregated α-synuclein protein. The gene discussed is GAK; the disease is Parkinson disease.